Navigation Links
Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronie's Disease
Date:10/11/2010

al results to differ from those contained in forward-looking statements. Given these risks and uncertainties, any or all of the forward-looking statements contained in this release may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements.

In addition, forward-looking statements provide the Company's expectations, plans or forecasts of future events and views as of the date of this release. The Company anticipates that subsequent events and developments will cause the Company's assessments to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's assessments as of any date subsequent to the date of this release. For More Information, Contact:James E. Fickenscher/CFO

William Q. Sargent Jr./ VP IRAuxilium Pharmaceuticals, Inc.

Auxilium Pharmaceuticals, Inc.(484) 321-5900

(484) 321-5926jfickenscher@auxilium.com

wsargent@auxilium.com
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
3. BioSpecifics Technologies Corp. Announces Auxilium XIAFLEX® Update
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
6. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
7. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
8. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
9. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
10. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
11. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... N.C. , May 22, 2013 STEPh, ... to announce the launch of their web site ( ... [STEPh Reports].  About STEPh Reports ... in development.  Each STEPh Report assesses ... trials data, projected launch year, company, and specific key ...
(Date:5/22/2013)... MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) would like ... recent company developments. As Medifirst continues to expand its ... shareholders. Integrating social media into its investor relations strategy, ... post updates on Twitter.  The Facebook homepage is Medifirst ... Says CEO Bruce J. Schoengood ...
(Date:5/22/2013)... 2013 Ranbaxy Laboratories Limited (hereafter, Ranbaxy), ... Daiichi Sankyo), announced on May 22 the actions ... address past conduct under prior management ... Sankyo continues to support Ranbaxy in its efforts ... past which led to the investigations by the ...
Breaking Medicine Technology:Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2Medifirst Solutions, Inc. Announces Update To Shareholders 2
(Date:5/22/2013)... (PRWEB) May 22, 2013 College ... have access to Adapt Courseware’s new Introduction ... an adaptive framework that responds based on each ... , the provider of comprehensive adaptive online curriculum ... continuing to develop introductory level general education offerings, ...
(Date:5/22/2013)... May 22, 2013 Beginning Aug. 22, ... the Conrad Foundation’s Spirit of Innovation Challenge . ... plan competition, free and open to students ages 13 ... Spirit of Innovation Challenge celebrates the life and entrepreneurial ... on the Moon. The program challenges teens to work ...
(Date:5/22/2013)... health officials from New Zealand, South Africa, Australia, Fiji ... countries to integrate rheumatic fever (RF) and rheumatic heart ... , "RHD was nearly eradicated in wealthy populations at ... a disease of poverty that kills children, adolescents and ... K. Srinath Reddy, President of the World Heart Federation. ...
(Date:5/22/2013)... TUESDAY, May 21 (HealthDay News) -- The overall health ... 10 people either overweight or obese and large numbers ... not exercising, a new government report shows. , , ... and Prevention, the report found Americans continuing to make ... soaring rates of heart disease, diabetes and other chronic ...
(Date:5/22/2013)... of Melbourne said this small increase in cancer risk ... scans in diagnosing and monitoring disease. , The study ... today and involved researchers at eight other centres ... Research on Cancer in Lyon, France. , Professor ... detailed three dimensional pictures to diagnose or exclude disease ...
Breaking Medicine News(10 mins):Health News:Adapt Courseware Releases Introduction to Sociology for Colleges and Universities Nationwide 2Health News:Adapt Courseware Releases Introduction to Sociology for Colleges and Universities Nationwide 3Health News:Conrad Foundation Announces 2013-2014 Spirit of Innovation Challenge Launch Date 2Health News:Governments hold long-overdue meeting on reducing early death from rheumatic heart disease 2Health News:Americans Still Making Unhealthy Choices: CDC 2Health News:Americans Still Making Unhealthy Choices: CDC 3Health News:Small increase in cancer risk following CT scans in childhood and adolescence 2
... (Nasdaq: ISIS ) announced that the Company will ... San Francisco, CA. Stanley T. Crooke, M.D., Ph.D., Chairman ... Company and an update on recent clinical and business activities.The ... on Monday, January 12, 2009. To access the live ...
... the leading,publisher of medical and scientific literature, announced ... American College of Cardiology,(ACC) ( http://www.acc.org ), the ... research. The agreement calls for Elsevier to publish,the ... of Cardiology,(JACC) ( http://www.elsevier.com/locate/jac ), for the ...
... hearty compared to other industries that have experienced massive layoffs lately. ... jobs in a single week, bringing the site,s job count to ... nursing profession, NursingCrossing aims to update its website with each and ... ...
... Jan. 8 Press Ganey Associates, Inc.,today announced ... of patient flow management tools and services for ... by,offering strategic solutions for patient flow issues such ... delayed surgeries, and lack of,available ICU and hospital ...
... Natural Alternatives International, Inc. ("NAI") (Nasdaq: ... marketer of customized nutritional supplements, today announced that ... Weaver,s employment with NAI ended.NAI also announced it ... Wells Fargo Bank. Among other changes the ...
... at Protecting Medicare Beneficiaries Introduced on the First ... Physical therapy services for ... arbitrary financial caps under legislation introduced Tuesday in ... the American Physical Therapy Association (APTA). The Medicare ...
Cached Medicine News:Health News:Isis Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference 2Health News:The American College of Cardiology Renews its Publishing Partnership With Elsevier 2Health News:The American College of Cardiology Renews its Publishing Partnership With Elsevier 3Health News:NursingCrossing Posts 12,000-Plus Nursing Jobs in a Week; Stresses the Need for Better Training and Working Conditions for Nurses 2Health News:NursingCrossing Posts 12,000-Plus Nursing Jobs in a Week; Stresses the Need for Better Training and Working Conditions for Nurses 3Health News:Press Ganey Acquires PatientFlow Technology 2Health News:Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension 2Health News:Senate and House Introduce Legislation to Repeal Therapy Caps 2Health News:Senate and House Introduce Legislation to Repeal Therapy Caps 3
... the hand, the Jarvik 2000 pump is about ... welded titanium shell sits a direct-current motor, a ... single moving part: a small, spinning titanium impeller ... to 7 liters per minute. Rather than take ...
... cardiac assist system primarily designed as a permanent ... failure., ,It is a blood pump that connects ... to help the ailing hearts pumping function and ... , ,It can also be used as a ...
... The Masimo SET LNOP Blue Sensor is ... babies. The LNOP Blue sensor is ... accuracy claims for cyanotic infants and children. ... presented challenging conditions for reliable and accurate ...
... The Trinity Biotech Captia™ Varicella-Zoster Virus (VZV) ... for the detection and quantitative determination of ... Individual serum specimens may be used for ... acute and convalescent, may be used to ...
Medicine Products: